Hospitals Are an Opportunity to Close the Osteoporosis Treatment Gap - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Leveraging Hospital Settings to Address the Osteoporosis Treatment Deficiency

  • By

  • Annie W. Yang

  • William W. Hung

  • Katherine Ritchey

  • October 5, 2026

Share

Clinical Report: Leveraging Hospital Settings to Address Osteoporosis Treatment Deficiency

Overview

A recent study highlights the significant under-treatment of osteoporosis following non-traumatic fractures, with only 6% of treatment-naïve patients receiving antifracture medications.

Background

Osteoporosis is a major public health concern, particularly following non-traumatic fractures, which can lead to increased morbidity and mortality. Despite the availability of effective antifracture medications, treatment initiation remains low, especially in comparison to secondary prevention practices for other conditions such as myocardial infarction.

Data Highlights

MetricValue
Patients admitted with non-traumatic fractures~10,000
Percentage of treatment-naïve patients receiving antifracture medication6%
Percentage of treated patients receiving therapy during hospitalization77%
Percentage of patients remaining on therapy post-discharge71%

Key Findings

  • 91% of patients admitted for non-traumatic fractures had not previously received osteoporosis treatment.
  • Only 6% of treatment-naïve patients received antifracture medication during hospitalization or as outpatients.
  • 77% of patients who received treatment did so during their hospital stay.
  • Factors associated with reduced likelihood of treatment included male sex, Black race, longer hospital stays, and femur fractures.
  • Patients discharged to skilled nursing facilities were less likely to receive medication, despite potential benefits.
  • Most patients who initiated medication during hospitalization continued therapy as outpatients (71%).

Clinical Implications

Healthcare providers should consider systematic approaches to ensure that osteoporosis is addressed during hospital admissions and transitions to outpatient care.

Conclusion

The study highlights the role of hospital settings in addressing osteoporosis treatment following fractures.

Related Resources & Content

  1. Silverstein et al., Journal of General Internal Medicine, 2023 -- Leveraging Hospital Settings to Address the Osteoporosis Treatment Deficiency
  2. The Journal of Clinical Endocrinology & Metabolism — Short-duration, Low-impact, High-intensity Osteogenic Loading for Postmenopausal Osteoporosis: A Quasi-experimental Case Series Analysis
  3. jadpro — Development of a Practice Standard for Monitoring Adult Patients Receiving Bone-Modifying Agents at a Community Cancer Center
  4. ASCO Publications — Endpoint comparison for osteoporosis assessment in cancer control studies (N02C1 and N03CC)
  5. MDSpire News — Fragility Fractures: Missed Opportunities in Treatment
  6. Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
  7. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians
  8. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024
  9. Quality ID #418 (CBE 0053): Osteoporosis Management in Women Who Had a Fracture
  10. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture | New England Journal of Medicine
  11. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis | New England Journal of Medicine
  12. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis | New England Journal of Medicine
  13. Zoledronic acid for hip fracture during initial hospitalization - PubMed
  14. Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
  15. Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative) - PMC

Original Source(s)

Related Content